XML 25 R7.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Series B
Preferred Stock
Common Stock
Common Stock to be Issued
Additional Paid-in Capital
Treasury Stock
Accumulated other Comprehensive Gain
Accumulated Deficit
Total
Balance at Dec. 31, 2021   $ 196   $ 47,674,364 $ (27,590,546) $ 20,084,014
Balance (in Shares) at Dec. 31, 2021   1,959,717 139          
Accretion of stock based compensation in connection with stock option grants 3,173,401 3,173,401
Accretion of stock-based professional fees in connection with stock option grants and shares   347,733 347,733
Shares issued for asset acquisition   $ 10   1,089,990   1,090,000
Shares issued for asset acquisition (in Shares)   100,000            
Net loss (12,138,572) (12,138,572)
Balance at Dec. 31, 2022   $ 206   52,285,488 (39,729,118) 12,556,576
Balance (in Shares) at Dec. 31, 2022   2,059,717 139          
Accretion of stock based compensation in connection with stock option grants       2,002,777 2,002,777
Accretion of stock-based professional fees in connection with stock option grants and shares       108,022 108,022
Issuance of common stock for prepaid professional services   $ 3   199,997 200,000
Issuance of common stock for prepaid professional services (in Shares)   34,102            
Sale of Series B preferred stock $ 200 800 1,000
Sale of Series B preferred stock (in Shares) 2,000,000              
Purchase of treasury stock $ (397,969) (397,969)
Purchase of treasury stock (in Shares)         66,945      
Accumulated other comprehensive gain         34,553 34,553
Rounding for reverse split $ 1 (1)
Rounding for reverse split (in Shares)   9,502            
Net loss         (8,404,970) (8,404,970)
Balance at Dec. 31, 2023 $ 200 $ 210 $ 54,597,083 $ (397,969) $ 34,553 $ (48,134,088) $ 6,099,989
Balance (in Shares) at Dec. 31, 2023 2,000,000 2,103,321 139   66,945